GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2024 | |
---|---|
Core EBITDA Growth(%) | - |
What is the latest Core EBITDA Growth ratio of GUFIC BIOSCIENCES ?
Year | Core EBITDA Growth |
---|---|
Mar2024 | - |
How is Core EBITDA Growth of GUFIC BIOSCIENCES Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2024 | 0 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,844.5 Cr | 8.5% | 7.1% | 9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | 8.5% |
7.1% |
9.8% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses